Tumor Suppressor Genes and Clonal Evolution in B-CLL

References

• Knudson A. G. J. Mutation and Cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Marshall C. J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246: 1406
   PubMed Web of Science ®Google Scholar
• Gallie B. L., Squire J. A., Goddard A., Dunn J. M., Canton M., Hinton D., Zhu X. P., Phillips R. A. Mechanism of oncogenesis in retinoblastoma. Lab. Invest 1990; 62: 394–408
   PubMed Web of Science ®Google Scholar
• Shew J., Ling N., Yang X., Fodstad O., Lee W. H. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene produce (ppl 11ORb-1) in osteosarcomas and synovial sarcomas. Oncogene Res 1989; 1: 205
   Google Scholar
• Friend S., Bernards R., Rogelj S., Weinberg R., Rapaport J., Albert D., Dryja T. A human DNA fragment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643
   PubMed Web of Science ®Google Scholar
• Lee E. H., To H., Shew J. Y., Bookstein R., Sculby P., Lee W. H. Inactivation of the retinoblastoma gene in human breast cancers. Science 1988; 241: 218
   PubMed Web of Science ®Google Scholar
• Brookstein R., Shew U. Y., Chen P. L., Scully P., Lee W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB-1 gene. Science (Washington DC) 1990; 247: 712–715
   PubMed Web of Science ®Google Scholar
• Presti J. C., Reuter V. C., Galan T., Fair W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 1991; 51: 5405–5409
   PubMed Web of Science ®Google Scholar
• Ishikawa J., Xu H. J., Hu S. X., Yandell D. W., Maeda S., Kamidono S., Benedict W. F., Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991; 51: 5736–5743
   PubMed Web of Science ®Google Scholar
• HaRb-lour J. W., LiSL Whang-Peng J., Gazdar A. F., Minna J. D., Kaye F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC) 1988; 241: 353–357
   PubMed Web of Science ®Google Scholar
• Yokota J., Adlyama T., Fung Y. K. Altered expression of the retinoblastoma (RB-1) gene in small cell carcinoma of the lung. Oncogene 1988; 3: 471–475
   PubMed Web of Science ®Google Scholar
• Xu -H. J., Hu S. X., Cagle P. T., Moore G., Benedict W. F. Absence of RB-1 protein expression in primary non-small cell lung carcinomas. Cancer Res 1991; 51: 2735–2739
   PubMed Web of Science ®Google Scholar
• Chen Y. C., Chen P. J., Yeh S. H., Tien H. F., Wang C. H., Tang J. L., Hong R. L. Delection of the human retinoblastoma gene in primary leukemias. Blood 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178–2181
   PubMed Web of Science ®Google Scholar
• Ahuja H., Jat P., Foti A., Bur-Eli M., Cline M. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Juliusson G., Oscier D. G., Fitchett M. Prognostic subgroups in B-cell chronic lymphocytic leukemia by specific chromosomal abnormalities. N. Engl. J. Med 1990; 323: 720–724
   PubMed Web of Science ®Google Scholar
• Juliusson G., Oscier D., Gahrton G. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk. Lymph. Suppl 1991; 5: 21–25
   PubMed Web of Science ®Google Scholar
• Liu Y., Grandér D., Söderhäll S., Juliusson G., Gahrton G., Einhorn S. Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chromosomes & Cancer 1992; 4: 250–256
   PubMed Web of Science ®Google Scholar
• Fuchett M., Griffiths M. J., Oscier D. G., Johnson S., Seabright M. Chromosome abnormalities involving band 13ql4' in hematologic malignancies. Cancer Genet. Cytogenet 1987; 24: 143–150
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Döhner H., Bulgay-Mörschel M., Weitz S., Bentz M., Lieter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukemia revealed by interphase cytogenetics. Blood 1993; 81: 2118–2124
   PubMed Web of Science ®Google Scholar
• Neubauer A., DeKant E., Rochlit C. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukemia. Brit. J. Haematol 1993; 85: 498–503
   PubMed Web of Science ®Google Scholar
• Lee W. H., Shew J. Y., Hong F. D., Sery T. W., Donoso L. A., Young L. J., Bookstein R., Lee E. Y. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1989; 329: 642–645
   Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Figge J., Shew J. Y., Huang C. M., Lee W. H., Marsilio E., Paucha E., Livingston D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–283
   PubMed Web of Science ®Google Scholar
• Ludlow J. W., DeCaprio J. A., Huang C-M., Lee W-H., Paucha E., Livingston D. M. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 1989; 56: 57–65
   PubMed Web of Science ®Google Scholar
• Kaelin W. G., Jr., Pallas D. C., DeCaprio J. A., Kaye F. J., Livingston D. M. Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product. Cell 1991; 64: 521–532
   PubMed Web of Science ®Google Scholar
• Chellappan S. P., Hiebert S., Mudryj M., Horowitz J. M., Nevins J. R. The E2F transcription factor is a cellular target for the RB-1 protein. Cell 1991; 65: 1053–1061
   PubMed Web of Science ®Google Scholar
• Bagchi S., Weinmann R., Raychaudhuri P. The retinoblastoma protein copurifies with E2F-1, an ElA-regulated inhibitor of the transcription factor E2F. Cell 1991; 65: 1063–1072
   PubMed Web of Science ®Google Scholar
• Shirodkar S., Ewen M., DeCaprio J. A., Morgan J., Livingston D. M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a 107-cyclin A complex in a cell cycle-regulated manner. Cell 1992; 68: 157–166
   PubMed Web of Science ®Google Scholar
• Defeo-Jones D., Hunang P. S., Jones R. E., Haskell K. M., Vuocolo G. A., Hanebik M. G., Huber H. E., Oliff A. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 1991; 352: 251–254
   PubMed Web of Science ®Google Scholar
• Hamel P. A., Gallie B. L., Phillips R. A. The retinoblastoma protein and cell cycle regulation. Trends Genet 1992; 8: 180–185
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• Chen P. L., Scully P., Shew J. Y., Wang J. Y., Lee W. -H. Phosphorylated of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58: 1193–1198
   PubMed Web of Science ®Google Scholar
• Lees J. A., Buchkovich K. J., Marshak D. R., Anderson C. W., Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J 1991; 10: 4279–4290
   PubMed Web of Science ®Google Scholar
• Hamel P. A., Cohen B. L., Sorce L. M., Gallie B. L., Phillips R. A. Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the Simian virus 40 large T-binding regions. Mol. Cell. Biol 1990; 10: 6586–6595
   PubMed Web of Science ®Google Scholar
• Harris C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993; 262: 1980–1981
   PubMed Web of Science ®Google Scholar
• Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinter A. C., Jessup J. M., van Tuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217–221
   PubMed Web of Science ®Google Scholar
• Zhu S. -M., Kusters I., Resau J. H., Trump B. F., Lane D. P., Harris C. C. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992; 52: 6092–6097
   PubMed Web of Science ®Google Scholar
• Diller L., Kassel J., Nelson C. E., Gryka M. A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S. J., Vogelstein B., Friend S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol 1990; 10: 5772–5781
   PubMed Web of Science ®Google Scholar
• Fults D., Brockmeyer D., Tulious M. W., Pedone C. A., Cawthorn R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992; 52: 674–679
   PubMed Web of Science ®Google Scholar
• Gusterson B. A., Anbazhagan R., Warren W., Midgely C., Lane D. P., O'Hare M., Stamps A., Carter R., Jayatilake J. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6: 1785–1789
   PubMed Web of Science ®Google Scholar
• Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff M. Z., Tainsky M. A., Friend S. H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250: 1233–1238
   PubMed Web of Science ®Google Scholar
• Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum M. L., Cavanee W., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846–847
   PubMed Web of Science ®Google Scholar
• Kelman Z., Prokocimer M., Peller S., Kohn Y., Rechair G., Manor Y., Cohen A., Rotter V. Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 1989; 74: 2318
   PubMed Web of Science ®Google Scholar
• Prokocimer M., Shaklai M., Ben Bassat H., Wolf D., Goldfinger N., Rotter V. Expression of p53 in human leukemia and lymphoma. Blood 1986; 68: 113
   PubMed Web of Science ®Google Scholar
• Cheng J., Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Molec. Cell Biol 1990; 10: 5502
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J., Inghirami G., Neri A., Newcomb E., Magrath I., Knowles D., Dalla-Favera R. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Koeffler H., Miller C., Nicolson M., Raynard J., Bosselman R. Increased expression of p53 protein in human leukemia cells. Proc. Nat. Acad. Sci. USA 1986; 83: 4035
   PubMed Web of Science ®Google Scholar
• Lubbert M., Miller C., Crawford L., Koeffler H. p53 in chronic myelogenous leukemia. J. Exp. Med 1988; 167: 873
   PubMed Web of Science ®Google Scholar
• Sugimoto K., Toyoshima H., Sakai R., Mujagawa K., Hagiwara K., Ishikawa F., Takaku F., Yazaki Y., Hirai H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 1992; 79: 2378
   PubMed Web of Science ®Google Scholar
• Feinstein E., Cimino G., Gale R., Alimena G., Berthier R., Kishi K., Goldman J., Zacceria A., Berrebi A., Cananni E. p53 chronic myelogenous leukemia in acute phase. Proc. Natl. Acad. Sci. USA 1991; 88: 6293
   PubMed Web of Science ®Google Scholar
• Gaidana G., Ballerini P., Gong J. Z. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Phillips R. A., Gill R. M., Zacksenhaus E. Why don't germline mutations in RB-11 predispose to leukemia. Curr. Topics in Micro. Immunol 1992; 182: 485–491
   PubMedGoogle Scholar
• Vogelstein B., Kinzler K. W. p53 function and dysfunction. Cell 1992; 70: 523–526
   PubMed Web of Science ®Google Scholar
• Levine A. J., Momand J., Finlay C. A. The p53 tumor suppressor gene. Nature 1991; 351: 453
   PubMed Web of Science ®Google Scholar
• Lane D. P., Benchimol S. p53: oncogene or anti-oncogene. Genes Der 1990; 4: 1
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancer. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874–879
   PubMed Web of Science ®Google Scholar
• Mori N., Wada M., Yokota J., Teraa M., Okada M., Teramura M., Masuda M., Hoshino S., Motoji T., Oshimi K. Mutations of the p53 tumour suppressor gene in haematologic neoplasms. Br. J. Haematol 1992; 81: 235–240
   PubMed Web of Science ®Google Scholar
• Fenaux P., Preudhomme C., Lai J. L., Quiquandon I., Jonveaux P., Vanrumbeke M., Sartiaux C., Morel P., Loucheux-Lefebvre M. H., Bauters F. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246–250
   PubMed Web of Science ®Google Scholar
• Soussi T., Jonveaux P. p53 gene alterations in human hematological malignancies: a review. Nouv. Rev. Fr. Hematol 1991; 33: 477–480
   PubMedGoogle Scholar
• Rouby S., Bayona W., Pisharody S. M., Newcomb E. W. p53 mutations in B-cell chronic lymphocytic leukemia. Curr. Top. Microbiol. Immunol 1992; 182: 313–317
   PubMedGoogle Scholar
• Fitchett M., Griffiths M. J., Oscier D. G., Johnson S., Seabright M. Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet. Cytogenet 1987; 24: 143–150
   PubMed Web of Science ®Google Scholar
• Peterson L. C., Lindquist L. L., Church S., Kay N. E. Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwestern patients. Genes. Chromosom. Cancer 1992; 4: 273–280
   PubMed Web of Science ®Google Scholar
• Zech L., Mellstedt H. Chromosome 13—a new marker for B-cell chronic lymphocytic leukemia. Hereditas 1988; 108: 77–84
   PubMed Web of Science ®Google Scholar
• Oscier D. G., Stevens J., Hamblin T. J., Pickering R. M., Lambert R., Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br. J. Haematol 1990; 76: 352–358
   PubMed Web of Science ®Google Scholar
• Kay N. E., Suen R., Ranheim E., Peterson L. C. Confirmation of Rb-1 gene defects in B-CLL clones and evidence for variable predominance of the Rb-1 defective cells within the CLL clone. Br. J. Haematol 1993; 84: 257–264
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Chromosomal translocations in lymphoid malignancies reveal novel prot-oncogenes. Annu. Rev. Immunol 1992; 10: 785–807
   PubMed Web of Science ®Google Scholar
• Hawthorn L. A., Chapman R., Oscier D., Cowell J. K. The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene, 8: 1415–1419
   PubMed Web of Science ®Google Scholar
• Liu Y., Szekely L., Grander D., Soderhall S., Juliusson G., Gahrton G., Linder S., Einhorn S. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB-11 gene: evidence for a role of an adjacent locus. Proc. Natl. Acad. Sci. USA, 90: 8697–8701
   PubMed Web of Science ®Google Scholar
• Brown A. G., Ross F. M., Dunne E. M., Steel C. M., Weir-Thompson E. M. Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telemeric to the retinoblastoma gene. Genetics 1993; 3: 67–72
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 77: 833–840
   PubMed Web of Science ®Google Scholar
• Raghoebier S., van Krieken J. H., Kluin-Nelemans J. C., Gillis A., van Ommen G. J., Ginsberg A. M., Raffeld M., Kluin P. M. Oncogene, rearrangements in chronic B-cell leukemia. Blood 1991; 77: 1560–1564
   PubMed Web of Science ®Google Scholar
• Draper G. J., Sanders B. M., Kinston J. E. Second primary neoplasms in patients with retinoblastoma. Br. J. Cancer 1986; 53: 661–671
   PubMed Web of Science ®Google Scholar
• Komblau S. M., Chen N., del Giglio A., O'Brien S., Deisseroth A. B. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res 1994; 54: 242–246
   PubMed Web of Science ®Google Scholar
• Nowell P. C., Moreau L., Growney P., Besa E. C. Karyotypic stability in chronic B-cell leukemia. Cancer Genet. Cytogenet 1988; 33: 155–160
   PubMed Web of Science ®Google Scholar
• Juliusson G., Friberg K., Gahrton G. Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. Cancer 1988; 62: 500–506
   PubMed Web of Science ®Google Scholar
• Juliusson G., Gahrton G. Chromosome Abnormalities in B-cell chronic lymphocytic leukemia. “Chronic Lymphocytic Leukemia”, B. D. Cheson. Dekker, New York 1993; 83–103
   Google Scholar
• Oscier D., Fitchett M., Herbert T., Lambert R. Karyotypic evolution in B-cell chronic lymphocytic leukaemia. Genes, Chromosomes & Cancer 1991; 3: 16–20
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Cytogenetically unrelated clones in hematologic neoplasms. Leukemia 1989; 3: 6–8
   PubMed Web of Science ®Google Scholar
• Peterson L., Blackstadt M., Kay N. Clonal evolution in chronic lymphocytic leukemia. “Chronic Lymphocytic Leukemia”, B. D. Cheson. Dekker, New York 1993; 181–196
   Google Scholar
• Peterson L. C., Lindquist L. L., Church S., Kay N. E. Frequent clonal abnormalities of chromosome band 13a14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwestern patients. Genes, Chromosomes and Cancer 1992; 4: 273–280
   PubMed Web of Science ®Google Scholar
• Matolcsy A., Inghirami G., Knowles D. Molecular genetic demonstration of the diverse evolution of Rchter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 1994; 83: 1363–1372
   PubMed Web of Science ®Google Scholar
• Nakamine H., Masih A., Sanger W., Wichert R., Mitchell D., Armitage J., Weisenburger D. Richter's syndrome with different immunoglobulin light chain types. Hematopathol 1991; 97: 656–663
   Google Scholar
• Nowell P., Finan J., Glover D., Guerry D. Cytogenetic evidence for the clonal nature of Richter's syndrome. Blood 1981; 58: 183–186
   PubMed Web of Science ®Google Scholar
• Bertoli L. F., Kubagawa H., Borzillo G. V., Mayumi M., Prchal J. T., Kearney J. F., Durant J. K., Cooper M. D. Analysis with anti-idiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome). Blood 1987; 709: 45
   Google Scholar
• Michiels J. J., van Dongen J. J. M., Hagemeijer A., Sonneveld P., Ploemacher R. E., Adriaansen J. H., van der Kwast Th. H., Brederoo P., Abels J. Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma. Leukemia 1989; 3: 819
   PubMed Web of Science ®Google Scholar
• Miyuamura K., Osada H., Yamauchi T., Itoh M., Kodera Y., Suchi T., Takahashi T., Ueda R. Single clonal origin of neoplastic B-cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer 1990; 66: 140
   PubMed Web of Science ®Google Scholar
• Han T., Ohtaki K., Sadamori N., Block A. W., Badey B., Ozer H., Sandberg A. A. Cytogenetic evidence for clonal evolution in B-cell chronic lymphocytic leukemia. Cancer Genet. Cytogenet 1986; 23: 321–328
   PubMed Web of Science ®Google Scholar
• Melo J. V., Brito-Babapulle V., do Socorro M., Oliveira P., Galton D. A. G., Catovsky D. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. Chronic Lymphocytic Leukemia. Recent Progress and Future Direction. 1987; 205–214
   Google Scholar
• Oscier D., Kruger A., Sadullah S., Chapman R., Hodges E., Hamblin T. Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome. Blood 1992; 80: 473a, (abstr, suppl.)
   Google Scholar
• Hamel P. A., Gill R. M., Phillips R. A., Gallie B. L. Transcriptional repression of the E2-containing promoters EllaE, C-myc and RB-1 by the product of the RB-1 gene. Mol. Cell. Biol 1992; 12: 3431–3438
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Sherr C. J., Matsushime H., Kato J. Y., Livingston D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73: 487–497
   PubMed Web of Science ®Google Scholar
• Hatzfeld J., Li M. L., Brown E. L., Sookdeo H., Levesque J. P., O'Toole T., Gurney C., Clark S. C., Hatzfeld A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor bl or Rb-l oligonucleotides. J. Exp. Med 1991; 174: 925–929
   PubMed Web of Science ®Google Scholar
• White L., Ortega J. A., Xing K. L. Acute non-lymphocytic leukemia following multi-modality therapy for retinoblastoma. Cancer 1985; 55: 496–498
   PubMed Web of Science ®Google Scholar
• Harper J. W., Adami G. R., Wei N. The p21 Cdk-interacting protein Cip I is a potent inhibitor of Gl cyclin-dependent kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• Hinds P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992; 70: 993–1006
   PubMed Web of Science ®Google Scholar
• El-Deiry W. S. WAFI, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Nobori T., Kaour M., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756
   PubMed Web of Science ®Google Scholar
• Kovesdi I., Reichel R., Nevins J. R. Role of an adenovirus E2 promoter binding factor in ElA-mediated coordinate gene control. Proc. Natl. Acad. Sci. USA 1987; 84: 2180–2184
   PubMed Web of Science ®Google Scholar
• Blake M. C., Azizkhan J. C. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol 1989; 9: 4994–5002
   PubMed Web of Science ®Google Scholar
• Rouby S., Costin T. A., Rosenberg C. R. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1 /MDR3 gene expression. Blood 1993; 82: 3452–3459
   PubMed Web of Science ®Google Scholar
• Sherr C. J. Mammalian Gl cyclins. Cell 1993; 73: 1059
   PubMed Web of Science ®Google Scholar